Kidney drug trial pulled before it even started
NCT ID NCT06120673
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This was a planned study to compare a newer drug, obinutuzumab, against a standard treatment (steroids plus cyclophosphamide) for people with primary membranous nephropathy, a kidney disease that causes protein leakage. The goal was to see which treatment worked better and had fewer side effects. However, the trial was withdrawn before enrolling any participants, so no results are available.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Obinutuzumab
What this could lead to
If successful, obinutuzumab could offer a new treatment option for primary membranous nephropathy with fewer side effects than current therapies.
What could go wrong
The trial was withdrawn before enrolling any participants, so no data is available. It is unclear if obinutuzumab is effective or safe for this condition.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY MEMBRANOUS NEPHROPATHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Bundaberg Hospital
Bundaberg, Queensland, Australia
-
Cairns Hospital
Cairns, Queensland, Australia
-
Canberra Hospital
Garran, Australian Capital Territory, Australia
-
Fiona Stanley Hospital
Murdoch, Western Australia, Australia
-
Logan Hospital
Logan City, Queensland, Australia
-
Mackay Base Hospital
Mackay, Queensland, Australia
-
Mater Hospital
South Brisbane, Queensland, Australia
-
Princess Alexandra Hospital
Woolloongabba, Queensland, Australia
-
Rockhampton Hospital
Rockhampton, Queensland, Australia
-
Royal Brisbane and Women's Hospital
Brisbane, Queensland, Australia
-
Royal Hobart Hospital
Hobart, Tasmania, Australia
-
Royal Prince Alfred Hospital
Camperdown, New South Wales, Australia
-
Sunshine Coast University Hospital
Birtinya, Queensland, Australia